Business
Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts
WOBURN, MA / ACCESSWIRE / August 29, 2023 / Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the
About this update from Biofrontera Inc.
[{"type":"text","content":"WOBURN, MA / ACCESSWIRE / August 29, 2023 / Biofrontera Inc. (NASDAQ:BFRI) (\"Biofrontera\" or the \"Company\"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announced today the appointment of Samantha (Sam) Widdicombe to the newly created position of Senior Director, Strategic Accounts and Communications. Biofrontera created this position in response to the growing demand and opportunity for specialized sales and marketing approaches resulting from an evolving landscape of medical practices consolidating into larger integrated organizations.Reporting to Mark Baldyga, Vice President of Sales and Marketing, Ms. Widdicombe joins Biofrontera with over 25 years of commercial leadership experience in the pharmaceutical industry, including 12 years in dermatology. She began her career in the United Kingdom with roles of increasing responsibility in sales and marketing before moving to the U.S. in 2011.\"Sam strengthens our team with considerable expertise and an extraordinary professional reputation in dermatology,\" said Hermann Luebbert, Chairman and Chief Executive Officer. \"Over the past few months we have expanded our sales organization and increased our investment in medical and commercial initiatives. This strategic appointment further demonstrates our commitment to investing in customer-facing initiatives and to growing sales.\"\"Sam's experience in working cross-functionally to execute sales tactics, identify targets and grow high-value accounts will help us achieve our strategic goals and drive product sales. I'm delighted to have her on our team and welcome her to Biofrontera,\" added Mr. Baldyga.\"I'm proud to join such a great organization and to support Biofrontera's commitment to the dermatology community and our patients. I look forward to working with the team, building new relationships in the industry and working with key accounts to expand the usage of Ameluz® across the U.S.,\" commented Ms. Widdicombe.Prior to joining Biofrontera, Ms. Widdicombe was Head of Strategic Communications at EPI Health/ Novan and previously served as Executive Director at Almirall, where she established their U.S. corporate communications function. Ms. Widdicombe began her career in dermatology at Allergan, where she was responsible for peer-to-peer initiatives for the medical dermatology ...